Aeolus Pharmaceuticals’ AEOL 20415 Protected Lungs Against Infection in CF Animal Model
Cystic Fibrosis, News
Results from a new animal study show that Aeolus Pharmaceuticals’ anti-microbial compound, AEOL 20415, may protect the lungs from infections in cystic fibrosis (CF). In the study, conducted in a ... Read more